{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:24:56Z","timestamp":1789878296192,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T00:00:00Z","timestamp":1362787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00428-013-1386-4","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T08:04:50Z","timestamp":1362729890000},"page":"455-464","source":"Crossref","is-referenced-by-count":11,"title":["Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS)"],"prefix":"10.1007","volume":"462","author":[{"given":"Friedrich","family":"Modde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Putri Andina","family":"Agustian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Wittig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian Ernst","family":"D\u00e4mmrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinzent","family":"Forstmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Vester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thurid","family":"Ahlenstiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Froede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Margret","family":"Wingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svjetlana","family":"Lovric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Thomas","family":"Kielstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mato","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Heinrich","family":"Kreipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Br\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens Luitpold","family":"Bockmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Ulrich","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,9]]},"reference":[{"key":"1386_CR1","first-page":"905","volume":"85","author":"C Gasser","year":"1955","unstructured":"Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R (1955) H\u00e4molytisch-ur\u00e4mische Syndrome: Bilaterale Nierenrindennekrosen bei akuten erworbenen h\u00e4molytischen An\u00e4mien. Schweiz Med Wschr 85:905\u2013909","journal-title":"Schweiz Med Wschr"},{"key":"1386_CR2","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1681\/ASN.2007010062","volume":"18","author":"K Desch","year":"2007","unstructured":"Desch K, Motto D (2007) Is there a shared pathophysiology for thrombotic thrombocytopenic purpura and hemolytic\u2013uremic syndrome? J Am Soc Nephrol 18:2457\u20132460","journal-title":"J Am Soc Nephrol"},{"key":"1386_CR3","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","volume":"290","author":"AX Garg","year":"2003","unstructured":"Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clark WF (2003) Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. J Am Med Assoc 290:1360\u20131370","journal-title":"J Am Med Assoc"},{"key":"1386_CR4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00467-003-1385-9","volume":"19","author":"CM Taylor","year":"2004","unstructured":"Taylor CM, Chua C, Howie AJ, Risdon RA (2004) Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome. Pediatr Nephrol 19:419\u2013425","journal-title":"Pediatr Nephrol"},{"key":"1386_CR5","doi-asserted-by":"crossref","first-page":"c177","DOI":"10.1159\/000218106","volume":"112","author":"W Zhang","year":"2009","unstructured":"Zhang W, Shi H, Ren H, Shen PY, Pan XX, Li X, Chen YX, Xu YW, Chen XN, Zhu P, Chen N (2009) Clinicopathological characteristics and outcome of Chinese patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a 9-year retrospective study. Nephron Clin Pract 112:c177\u2013c183","journal-title":"Nephron Clin Pract"},{"key":"1386_CR6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","volume":"151","author":"MA Karmali","year":"1985","unstructured":"Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H (1985) The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151:775\u2013782","journal-title":"J Infect Dis"},{"key":"1386_CR7","first-page":"1073","volume":"365","author":"PI Tarr","year":"2005","unstructured":"Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073\u20131086","journal-title":"Lancet"},{"key":"1386_CR8","first-page":"959","volume":"108","author":"AD Proia","year":"1984","unstructured":"Proia AD, Harden EA, Silberman HR (1984) Mitomycin-induced hemolytic\u2013uremic syndrome. Arch Pathol Lab Med 108:959\u2013962","journal-title":"Arch Pathol Lab Med"},{"key":"1386_CR9","first-page":"54","volume":"98","author":"D Buren Van","year":"1985","unstructured":"Van Buren D, Van Buren CT, Flechner SM, Maddox AM, Verani R, Kahan BD (1985) De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine. Surgery 98:54\u201362","journal-title":"Surgery"},{"key":"1386_CR10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","volume":"6","author":"C Loirat","year":"2011","unstructured":"Loirat C, Fremeaux-Bacchi V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6:60","journal-title":"Orphanet J Rare Dis"},{"key":"1386_CR11","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","volume":"112","author":"V Fremeaux-Bacchi","year":"2008","unstructured":"Fremeaux-Bacchi V, Miller EC, Liszewski MK, Strain L, Blouin J, Brown AL, Moghal N, Kaplan BS, Weiss RA, Lhotta K, Kapur G, Mattoo T, Nivet H, Wong W, Gie S, Hurault de Ligny B, Fischbach M, Gupta R, Hauhart R, Meunier V, Loirat C, Dragon-Durey MA, Fridman WH, Janssen BJ, Goodship TH, Atkinson JP (2008) Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112:4948\u20134952","journal-title":"Blood"},{"key":"1386_CR12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/jmg.40.9.676","volume":"40","author":"HP Neumann","year":"2003","unstructured":"Neumann HP, Salzmann M, Bohnert-Iwan B, Mannuelian T, Skerka C, Lenk D, Bender BU, Cybulla M, Riegler P, Konigsrainer A, Neyer U, Bock A, Widmer U, Male DA, Franke G, Zipfel PF (2003) Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J Med Genet 40:676\u2013681","journal-title":"J Med Genet"},{"key":"1386_CR13","first-page":"110","volume":"46","author":"RA Thompson","year":"1981","unstructured":"Thompson RA, Winterborn MH (1981) Hypocomplementaemia due to a genetic deficiency of beta 1H globulin. Clin Exp Immunol 46:110\u2013119","journal-title":"Clin Exp Immunol"},{"key":"1386_CR14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","volume":"104","author":"E Goicoechea de Jorge","year":"2007","unstructured":"Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, Carreras L, Arranz EA, Garrido CA, Lopez-Trascasa M, Sanchez-Corral P, Morgan BP, Rodriguez de Cordoba S (2007) Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A 104:240\u2013245","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1386_CR15","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","volume":"41","author":"V Fremeaux-Bacchi","year":"2004","unstructured":"Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, Vigneau C, Kuypers D, Boudailliez B, Loirat C, Rondeau E, Fridman WH (2004) Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 41:e84","journal-title":"J Med Genet"},{"key":"1386_CR16","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2005010103","volume":"16","author":"D Kavanagh","year":"2005","unstructured":"Kavanagh D, Kemp EJ, Mayland E, Winney RJ, Duffield JS, Warwick G, Richards A, Ward R, Goodship JA, Goodship TH (2005) Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol 16:2150\u20132155","journal-title":"J Am Soc Nephrol"},{"key":"1386_CR17","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","volume":"108","author":"J Caprioli","year":"2006","unstructured":"Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, Mele C, Bresin E, Cassis L, Gamba S, Porrati F, Bucchioni S, Monteferrante G, Fang CJ, Liszewski MK, Kavanagh D, Atkinson JP, Remuzzi G (2006) Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108:1267\u20131279","journal-title":"Blood"},{"key":"1386_CR18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","volume":"361","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM (2009) Thrombomodulin mutations in atypical hemolytic\u2013uremic syndrome. N Engl J Med 361:345\u2013357","journal-title":"N Engl J Med"},{"key":"1386_CR19","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.molimm.2009.04.012","volume":"46","author":"AL Stahl","year":"2009","unstructured":"Stahl AL, Kristoffersson A, Olin AI, Olsson ML, Roodhooft AM, Proesmans W, Karpman D (2009) A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome. Mol Immunol 46:2236\u20132243","journal-title":"Mol Immunol"},{"key":"1386_CR20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","volume":"16","author":"MA Dragon-Durey","year":"2005","unstructured":"Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, Weiss L, Fridman WH, Fremeaux-Bacchi V (2005) Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 16:555\u2013563","journal-title":"J Am Soc Nephrol"},{"key":"1386_CR21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1160\/TH08-05-0322","volume":"101","author":"C Skerka","year":"2009","unstructured":"Skerka C, Jozsi M, Zipfel PF, Dragon-Durey MA, Fremeaux-Bacchi V (2009) Autoantibodies in haemolytic uraemic syndrome (HUS). Thromb Haemost 101:227\u2013232","journal-title":"Thromb Haemost"},{"key":"1386_CR22","doi-asserted-by":"crossref","unstructured":"Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, Schmidt CQ, Staniforth SJ, Holmes LV, Ward R, Morgan L, Goodship TH, Marchbank KJ Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome Blood 115:379\u2013387","DOI":"10.1182\/blood-2009-05-221549"},{"key":"1386_CR23","first-page":"219","volume-title":"Thrombose und Embolie. Gef\u00e4ssentz\u00fcndung und septische Infektion. Gesammelte Abhandlungen zur wissenschaftlichen Medicin","author":"RC Virchow","year":"1856","unstructured":"Virchow RC (1856) Thrombose und Embolie. Gef\u00e4ssentz\u00fcndung und septische Infektion. Gesammelte Abhandlungen zur wissenschaftlichen Medicin. von Meindinger & Sohn, Frankfurt am Main, pp 219\u2013723"},{"key":"1386_CR24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1084\/jem.153.3.665","volume":"153","author":"B Ghebrehiwet","year":"1981","unstructured":"Ghebrehiwet B, Silverberg M, Kaplan AP (1981) Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med 153:665\u2013676","journal-title":"J Exp Med"},{"key":"1386_CR25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","volume":"12","author":"M Huber-Lang","year":"2006","unstructured":"Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, Gebhard F, Younger JG, Drouin SM, Wetsel RA, Ward PA (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12:682\u2013687","journal-title":"Nat Med"},{"key":"1386_CR26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0038-1655974","volume":"77","author":"K Ikeda","year":"1997","unstructured":"Ikeda K, Nagasawa K, Horiuchi T, Tsuru T, Nishizaka H, Niho Y (1997) C5a induces tissue factor activity on endothelial cells. Thromb Haemost 77:394\u2013398","journal-title":"Thromb Haemost"},{"key":"1386_CR27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood.V68.4.875.875","volume":"68","author":"T Wiedmer","year":"1986","unstructured":"Wiedmer T, Esmon CT, Sims PJ (1986) Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase. Blood 68:875\u2013880","journal-title":"Blood"},{"key":"1386_CR28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1056\/NEJM199209103271102","volume":"327","author":"JM Bergstein","year":"1992","unstructured":"Bergstein JM, Riley M, Bang NU (1992) Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome. N Engl J Med 327:755\u2013759","journal-title":"N Engl J Med"},{"key":"1386_CR29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0753-3322(96)89668-5","volume":"50","author":"A Sagripanti","year":"1996","unstructured":"Sagripanti A, Carpi A, Baicchi U, Morganti M, Rosaia B, Nicolini A, Mittermayer C (1996) Plasmatic parameters of coagulation activation in thrombotic microangiopathy. Biomed Pharmacother 50:357\u2013362","journal-title":"Biomed Pharmacother"},{"key":"1386_CR30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1440-1754.2000.00532.x","volume":"36","author":"AA Martin","year":"2000","unstructured":"Martin AA, Woolven BL, Harris SJ, Keeley SR, Adams LD, Jureidini KF, Henning PH (2000) Plasminogen activator inhibitor type-1 and interleukin-6 in haemolytic uraemic syndrome. J Paediatr Child Health 36:327\u2013331","journal-title":"J Paediatr Child Health"},{"key":"1386_CR31","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.1998.00103.x","volume":"54","author":"C Geet Van","year":"1998","unstructured":"Van Geet C, Proesmans W, Arnout J, Vermylen J, Declerck PJ (1998) Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome. Kidney Int 54:1324\u20131330","journal-title":"Kidney Int"},{"key":"1386_CR32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<9::AID-AJH3>3.0.CO;2-T","volume":"59","author":"MT Anthony","year":"1998","unstructured":"Anthony MT, Zeigler ZR, Lister J, Raymond JM, Shadduck RK, Kramer RE, Gryn JF, Rintels PB, Besa EC, George JN, Silver B, Joyce R, Bodensteiner D (1998) Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation. Am J Hematol 59:9\u201314","journal-title":"Am J Hematol"},{"key":"1386_CR33","first-page":"55","volume":"33","author":"E Rondeau","year":"1990","unstructured":"Rondeau E, Mougenot B, Lacave R, Peraldi MN, Kruithof EK, Sraer JD (1990) Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies. Clin Nephrol 33:55\u201360","journal-title":"Clin Nephrol"},{"key":"1386_CR34","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/ki.1996.523","volume":"50","author":"Y Xu","year":"1996","unstructured":"Xu Y, Hagege J, Mougenot B, Sraer JD, Ronne E, Rondeau E (1996) Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Kidney Int 50:2011\u20132019","journal-title":"Kidney Int"},{"key":"1386_CR35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"1386_CR36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"1386_CR37","unstructured":"World Medical Association (2008) WMA Declaration of Helsinki \u2014 Ethical Principles for Medical Research Involving Human Subjects. http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/ . Accessed 12 Jan 2013"},{"key":"1386_CR38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1538-7836.2008.03220.x","volume":"7","author":"DC Rijken","year":"2009","unstructured":"Rijken DC, Lijnen HR (2009) New insights into the molecular mechanisms of the fibrinolytic system. J Thromb Haemost 7:4\u201313","journal-title":"J Thromb Haemost"},{"key":"1386_CR39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9343(82)90717-3","volume":"73","author":"JM Bergstein","year":"1982","unstructured":"Bergstein JM, Kuederli U, Bang NU (1982) Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndrome. Am J Med 73:322\u2013327","journal-title":"Am J Med"},{"key":"1386_CR40","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.biocel.2012.05.020","volume":"44","author":"SC Slater","year":"2012","unstructured":"Slater SC, Ramnath RD, Uttridge K, Saleem MA, Cahill PA, Mathieson PW, Welsh GI, Satchell SC (2012) Chronic exposure to laminar shear stress induces Kruppel-like factor 2 in glomerular endothelial cells and modulates interactions with co-cultured podocytes. Int J Biochem Cell Biol 44:1482\u20131490","journal-title":"Int J Biochem Cell Biol"},{"key":"1386_CR41","unstructured":"Hershko K, Simhadri V, Blaisdell A, Hunt RC, Newell J, Tseng SC, Hershko AY, Choi JW, Sauna ZE, Wu A, Bram RJ, Komar AA, Kimchi-Sarfaty C (2012) Cyclosporin A impairs the secretion and activity of ADAMTS13 J Biol Chem"},{"key":"1386_CR42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00281-011-0282-8","volume":"34","author":"EM Conway","year":"2012","unstructured":"Conway EM (2012) Thrombomodulin and its role in inflammation. Semin Immunopathol 34:107\u2013125","journal-title":"Semin Immunopathol"},{"key":"1386_CR43","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00467-003-1236-8","volume":"18","author":"GC Fernandez","year":"2003","unstructured":"Fernandez GC, Te Loo MW, van der Velden TJ, van der Heuvel LP, Palermo MS, Monnens LL (2003) Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome. Pediatr Nephrol 18:1066\u20131068","journal-title":"Pediatr Nephrol"},{"key":"1386_CR44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","volume":"187","author":"M Morigi","year":"2011","unstructured":"Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C (2011) Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 187:172\u2013180","journal-title":"J Immunol"},{"key":"1386_CR45","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204:1257\u20131265","journal-title":"J Exp Med"},{"key":"1386_CR46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-385526-8.00010-2","volume":"61","author":"S Deaglio","year":"2011","unstructured":"Deaglio S, Robson SC (2011) Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol 61:301\u2013332","journal-title":"Adv Pharmacol"},{"key":"1386_CR47","first-page":"1","volume":"31","author":"G Cvirn","year":"2001","unstructured":"Cvirn G, Gallistl S, Muntean W (2001) Alpha-2-macroglobulin inhibits the anticoagulant action of activated protein C in cord and adult plasma. Haemostasis 31:1\u201311","journal-title":"Haemostasis"},{"key":"1386_CR48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0038-1651570","volume":"69","author":"M Levi","year":"1993","unstructured":"Levi M, Roem D, Kamp AM, de Boer JP, Hack CE, ten Cate JW (1993) Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo. Thromb Haemost 69:141\u2013146","journal-title":"Thromb Haemost"},{"key":"1386_CR49","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1021\/bi00392a053","volume":"26","author":"JC Meijers","year":"1987","unstructured":"Meijers JC, Tijburg PN, Bouma BN (1987) Inhibition of human blood coagulation factor Xa by alpha 2-macroglobulin. Biochemistry 26:5932\u20135937","journal-title":"Biochemistry"},{"key":"1386_CR50","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1021\/bi00606a030","volume":"17","author":"MR Downing","year":"1978","unstructured":"Downing MR, Bloom JW, Mann KG (1978) Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry 17:2649\u20132653","journal-title":"Biochemistry"},{"key":"1386_CR51","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0168-8278(97)80455-2","volume":"26","author":"AM Tiggelman","year":"1997","unstructured":"Tiggelman AM, Linthorst C, Boers W, Brand HS, Chamuleau RA (1997) Transforming growth factor-beta-induced collagen synthesis by human liver myofibroblasts is inhibited by alpha2-macroglobulin. J Hepatol 26:1220\u20131228","journal-title":"J Hepatol"},{"key":"1386_CR52","doi-asserted-by":"crossref","first-page":"39096","DOI":"10.1074\/jbc.M601362200","volume":"281","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Ge G, Greenspan DS (2006) Inhibition of bone morphogenetic protein 1 by native and altered forms of alpha2-macroglobulin. J Biol Chem 281:39096\u201339104","journal-title":"J Biol Chem"},{"key":"1386_CR53","doi-asserted-by":"crossref","first-page":"p32","DOI":"10.1159\/000101798","volume":"106","author":"V Eremina","year":"2007","unstructured":"Eremina V, Baelde HJ, Quaggin SE (2007) Role of the VEGF\u2014a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol 106:p32\u2013p37","journal-title":"Nephron Physiol"},{"key":"1386_CR54","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/01.STR.27.6.1066","volume":"27","author":"A Lindgren","year":"1996","unstructured":"Lindgren A, Lindoff C, Norrving B, Astedt B, Johansson BB (1996) Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke 27:1066\u20131071","journal-title":"Stroke"},{"key":"1386_CR55","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1055\/s-0037-1615115","volume":"79","author":"PJ Kesteren van","year":"1998","unstructured":"van Kesteren PJ, Kooistra T, Lansink M, van Kamp GJ, Asscheman H, Gooren LJ, Emeis JJ, Vischer UM, Stehouwer CD (1998) The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. Thromb Haemost 79:1029\u20131033","journal-title":"Thromb Haemost"},{"key":"1386_CR56","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood-2002-01-0046","volume":"100","author":"RJ Dekker","year":"2002","unstructured":"Dekker RJ, van Soest S, Fontijn RD, Salamanca S, de Groot PG, VanBavel E, Pannekoek H, Horrevoets AJ (2002) Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 100:1689\u20131698","journal-title":"Blood"},{"key":"1386_CR57","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbrc.2009.12.002","volume":"391","author":"G Villarreal Jr","year":"2010","unstructured":"Villarreal G Jr, Zhang Y, Larman HB, Gracia-Sancho J, Koo A, Garcia-Cardena G (2010) Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells. Biochem Biophys Res Commun 391:984\u2013989","journal-title":"Biochem Biophys Res Commun"},{"key":"1386_CR58","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1182\/blood-2006-07-036020","volume":"109","author":"JO Fledderus","year":"2007","unstructured":"Fledderus JO, van Thienen JV, Boon RA, Dekker RJ, Rohlena J, Volger OL, Bijnens AP, Daemen MJ, Kuiper J, van Berkel TJ, Pannekoek H, Horrevoets AJ (2007) Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2. Blood 109:4249\u20134257","journal-title":"Blood"},{"key":"1386_CR59","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/01.RES.0000159707.05637.a1","volume":"96","author":"Z Lin","year":"2005","unstructured":"Lin Z, Kumar A, SenBanerjee S, Staniszewski K, Parmar K, Vaughan DE, Gimbrone MA Jr, Balasubramanian V, Garcia-Cardena G, Jain MK (2005) Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 96:e48\u2013e57","journal-title":"Circ Res"},{"key":"1386_CR60","first-page":"446","volume":"31","author":"RJ Zhang","year":"2010","unstructured":"Zhang RJ, Yang LH, Zhang Y, Zhou JF, Cao Y, Chen CH (2010) Effect of antisense KLF4 gene on the expression of vWF and PAI-1 in endothelium cells. Zhonghua Xue Ye Xue Za Zhi 31:446\u2013450","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"1386_CR61","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V100.2.517","volume":"100","author":"J Wojta","year":"2002","unstructured":"Wojta J, Kaun C, Zorn G, Ghannadan M, Hauswirth AW, Sperr WR, Fritsch G, Printz D, Binder BR, Schatzl G, Zwirner J, Maurer G, Huber K, Valent P (2002) C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils. Blood 100:517\u2013523","journal-title":"Blood"},{"key":"1386_CR62","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1538-7836.2006.02046.x","volume":"4","author":"SP Kastl","year":"2006","unstructured":"Kastl SP, Speidl WS, Kaun C, Rega G, Assadian A, Weiss TW, Valent P, Hagmueller GW, Maurer G, Huber K, Wojta J (2006) The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation. J Thromb Haemost 4:1790\u20131797","journal-title":"J Thromb Haemost"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1386-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-013-1386-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1386-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T11:33:12Z","timestamp":1595503992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-013-1386-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,9]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["1386"],"URL":"https:\/\/doi.org\/10.1007\/s00428-013-1386-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,9]]}}}